socalTECH

MAY 18, 2021

Los Angeles-based Narrativa, a developer of artificial intelligence software aimed at helping pharmaceutical companies with FDA drug approvals, says it has raised $1.3M According to Narrativa, it is using its AI software to automate the generation of Clinical Study Reports (CSRs) and other regulatory reports.

Artificial Inteligence 113

Artificial Inteligence Study Report Los Angeles 113

Xconomy

SEPTEMBER 30, 2020

Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as the companies now look ahead to pivotal studies testing that compound in several inherited forms of the disorder.

Statistics 111

Statistics Study Report Research 111

Xconomy

JUNE 11, 2020

Less than a month after reporting preliminary early-stage data for its experimental vaccine for the novel coronavirus, Moderna has finalized the plan for a Phase 3 test. The study, set to begin next month, is targeting enrollment of about 30,000 volunteers, Moderna (NASDAQ: MRNA ) announced Thursday.

Study 101

Study Report San Diego Research 101

Xconomy

JULY 6, 2016

The Obama administration’s push to sign up one million Americans for a long-term health study will start in New York, Pittsburgh, Chicago, and Tucson, AZ, top health officials said today. The VA is running its own long-term study with nearly half a million participants so far.).

Study 59

Study PMI San Diego Sample 59

Xconomy

NOVEMBER 2, 2018

The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells. Studies of CRISPR-Cas9 to treat human disease are about to start, too. This week, we reported on a new study that raises exactly that question.

Study 74

Study Startup Research Report 74

TechCrunch LA

FEBRUARY 24, 2020

SpaceX is serious about iteration – its strategy of building (and failing – and learning from its failures) fast is in full effect for its Starship development program. It’s said to be seeking $250 million in a round that could close as early as mid-March, according to a CNBC report.

SpaceX 153

SpaceX Sample Study Newsletter 153

socalTECH

OCTOBER 18, 2017

Playa Vista-based hyperloop developer Hyperloop Transportation Technologies --the company led by Dirk Ahlborn and Bibop Gresta--says it has linked up with insurance company Munich Re on a risk analysis and feasibility effort. The other companies are the similar named Virgin Hyperloop One in downtown Los Angeles, and SpaceX, in Hawthorne.

Technology 124

Technology SpaceX Hawthorne Study 124

Startup Professionals Musings

JANUARY 22, 2017

Zak is the director of the Center for Neuroeconomics Studies at Claremont Graduate University, and he has studied the connection between trust and performance all over the world. A recent Gallup survey reported that 81 percent of employees would prefer to manage themselves, if their company created the right culture for it.

Develop 58

Develop Development Claremont Mentor 58

socalTECH

MAY 10, 2013

Carlsbad-based biopharmaceuticals developer Isis Pharmaceuticals reported Thursday that it has received $3.5M The company said the payment was received as part of a Phase 2 study milestone of a treatment for infants with spinal muscular atrophy (SMA). in a milestone payment, from Biogen Idec. READ MORE>>.

Study 138

Study Report Develop Development 138

Xconomy

AUGUST 14, 2020

The road of drug development is rife with detours and disappointments but Seres Therapeutics showed this week that course corrections can work. Four years after its microbiome therapy failed in a mid-stage study, the company reported early positive data from a pivotal test of its treatment for a type of gut infection.

Study 63

Study Course Report Company 63

TechCrunch LA

MARCH 19, 2021

Earlier this month, Los Angeles became the latest city to task its various departments with prepping a feasibility study for deploying new software and monitoring technologies to better account for its carbon footprint. Los Angeles has tried to address its carbon footprint in the past, but the efforts weren’t very successful.

Los Angeles 192

Los Angeles Marketing Study Angel 192

Xconomy

SEPTEMBER 15, 2016

That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship. The Connect Innovation Report found that 405 software, technology, and life sciences startups were created last year in San Diego County.

San Diego 40

San Diego Report High Tech Study 40

Xconomy

SEPTEMBER 9, 2019

On Monday, Acadia (NASDAQ: ACAD ) reported that its drug, pimavanserin, met the goal of delaying relapse of psychosis in dementia patients compared to a placebo.

San Diego 74

San Diego Study Report Company 74

TechCrunch LA

APRIL 21, 2020

The Verge was the first to report the story. Our learnings and developments from Maven will go on to benefit and accelerate the growth of other areas of GM business.”. The company sent an email to customers Tuesday that after examining the business, the car-sharing industry and COVID-19, it decided to shutter the service permanently.

Los Angeles 215

Los Angeles Technical Review Email Services 215

Startup Professionals Musings

JULY 28, 2021

He has completed a study of more than 100 CEOs, with feedback from over 8,000 of their employees on this topic. Developed a higher level of mental complexity. High scoring leaders seek and positively respond to feedback from three critical groups: peers, customers, and direct reporting team members.

Entrepreneur 165

Entrepreneur Mentor Ideas Invest 165

Xconomy

AUGUST 22, 2016

The developer also provides rent-free space for a second EvoNexus incubator in University City (about a mile or so from UC San Diego) and a third EvoNexus incubator near UC Irvine that opened at the end of 2014. In April, a study released by the San Diego Regional Economic Development Corp.

Develop 40

Develop Development San Diego Startup 40

socalTECH

OCTOBER 11, 2011

Researchers at the California Institute of Technology reported last week that they have created a "smart petri dish" which uses Google smart phones and Lego blocks, to automatically monitor cell growth in petri dishes. Usually, petri dishes are placed in incubators, removed for examination, and manually studied under a microscope.

CalTech 162

CalTech Google Incubator Study 162

Startup Professionals Musings

JULY 9, 2022

Nevertheless, there is nothing wrong with studying and learning from the wisdom and experience of others. Everyday devices, like Internet soda vending , have an embedded computer allowing full remote reporting and control. So for those of you that love checklists, I saw some real value in the classic book by James M. Mobile Computing.

Technology 133

Technology Cloud Computing Social Media Networking 133

Xconomy

NOVEMBER 7, 2016

Up until this point, studies of an experimental drug from Biogen and Ionis Pharmaceuticals had focused on patients with the most severe form of a rare, potentially deadly genetic disorder called spinal muscular atrophy. Biogen enrolled 126 patients in the study; 84 got nusinersen while 42 got a placebo.

Help 97

Help Study Research Statistics 97

Xconomy

DECEMBER 20, 2016

An Acadia Pharmaceuticals drug developed to treat hallucinations and delusions experienced by Parkinson’s disease patients is now showing signs it could also treat similar psychoses associated with Alzheimer’s disease.

San Diego 40

San Diego Statistics Study News 40

Startup Professionals Musings

APRIL 28, 2021

Thus I was pleased to see my own insights covered in a new book, “ Why Startups Fail ,” by Tom Eisenmann, a Harvard Business School professor, who has mentored many more entrepreneurs, and authored more than a hundred HBS case studies from real-world startups. Even non-profits need income to run a business.

Technical Review 131

Technical Review Case Study Mentor Software Review 131

Xconomy

SEPTEMBER 2, 2016

As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson. The firm has nabbed $451 million toward its goal of $600 million. The firm raised $450 million in January 2015.

News 57

News San Diego Journal Technical Review 57

Xconomy

OCTOBER 7, 2016

—Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. She refused to discuss Edison at the time. Officials declined to say how many of the 18 were taking the drug and how many were on placebo.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

AUGUST 1, 2016

The most advanced of those therapies is a treatment developed by Carlsbad, CA-based Ionis Pharmaceuticals, and today that drug, known as nusinersen, took an important step forward. Biogen also said that because of the data, it will stop the ongoing study, a 122-patient, placebo-controlled trial known as Endear, early.

Study 40

Study Research Statistics Help 40

Startup Professionals Musings

JANUARY 7, 2019

In fact, according to the latest Index of Startup Activity by the Kauffman Foundation and recent press reports , these Baby Boomers are actually driving a new entrepreneurship boom. Here are some indicative entrepreneurial facts from recent Kauffman studies and others. percent to 24.3 percent last year.

Startup 119

Startup Technical Review Technical Support Entrepreneur 119

Xconomy

AUGUST 17, 2016

Avelas plans to use the new funding to advance development of AVB-620, the company’s lead diagnostic agent, for use in breast cancer surgeries, CEO Carmine Stengone told me yesterday. The Phase 1b study also determined a preferred dose for the next stage in the study. and San Diego’s Avalon Ventures. Carmine Stengone.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

JULY 18, 2016

The company is developing a nasal formulation of metoclopramide, , an already-approved treatment for digestive pain and other symptoms related to the stomach being unable to empty its contents. Evoke’s late-stage study failed to show a significant benefit to the drug, EVK-001, versus placebo at all 41 of the sites that tested it nationally.

Study 40

Study Sites News Research 40

Xconomy

NOVEMBER 3, 2016

Bluebird Bio is releasing new data this morning that speak to both the potential and the limitations of a gene therapy it’s been developing for two deadly blood diseases, sickle cell disease and beta-thalassemia. In beta-thalassemia, the story remains very much the same for Bluebird as in previous releases of data from the studies.

Study 40

Study San Diego Course Organization 40

Xconomy

AUGUST 8, 2016

After reporting encouraging news last week from a mid-stage trial of its lead anti-cancer drug, San Diego’s MEI Pharma (NASDAQ: MEIP ) said it has signed a drug development deal with the Swiss pharmaceutical group Helsinn that could eventually be worth over $464 million. Reprints | Share:

Study 40

Study San Diego News Design 40

Tech Zulu Event

AUGUST 26, 2015

A uStamp study reported 65% of companies allow employees to work remotely and 69 percent of remote employees say they feel liberated being able to work away from the office. According to Talent Development , 46% of remote employees say they feel isolated due to a lack of face-to-face contact with team members.

Study 40

Study Technical Review Product Report 40

Startup Professionals Musings

SEPTEMBER 29, 2019

Nevertheless, there is nothing wrong with studying and learning from the wisdom and experience of others. Everyday devices, like Internet soda vending , have an embedded computer allowing full remote reporting and control. So for those of you that love checklists, I saw some real value in the classic book by James M. Mobile Computing.

Technology 86

Technology Cloud Computing Social Media Networking 86

Xconomy

JULY 20, 2016

First came Inception Sciences , a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. We really have a development focus,” Martin told me. “We But it’s structured differently. We tried to learn from what everyone else has done.”.

San Diego 40

San Diego Avalon Outsource Development Newsletter 40

Xconomy

AUGUST 19, 2016

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. STAT found the figures in Editas’s quarterly earnings report.

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

SEPTEMBER 30, 2016

Who will break free of the pack of companies developing drugs meant to prevent migraines? —Amgen (NASDAQ: AMGN ), of Thousand Oaks, CA, and partner Novartis released positive results from the first Phase 3 trial of erenumab , one of a group of drugs being developed to prevent migraines , not just lessen their impact when they happen.

Avalon 40

Avalon Thousand Oaks Study Startup 40

Startup Professionals Musings

APRIL 24, 2015

He just completed a study of more than 100 CEOs, with feedback from over 8,000 of their employees on this topic. Developed a higher level of mental complexity. High scoring leaders seek and positively respond to feedback from three critical groups: peers, customers, and direct reporting team members.

Mentor 104

Mentor Ideas Entrepreneur Study 104

Xconomy

SEPTEMBER 7, 2016

Blinding many studies is futile, say clinicians. “A number of patients are sick and tired of chemo, so they’ll roll the dice, knowing they won’t stay on the study” if they are assigned to take chemo, says Andrew Ko, a gastrointestinal cancer specialist at the University of California, San Francisco.

Study 40

Study Research San Diego Design 40

Xconomy

OCTOBER 20, 2016

As Xconomy reported last year, South San Francisco, CA-based BlackThorn was spun out of Scripps Research Institute , which on its website lists the company as one of its 2013 spinouts. Developing drugs for neurobehavioral diseases is difficult for a number of reasons. It’s emerging from clinical research.”.

Research 40

Research Study Press Equity 40